Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IKT

IKT News

Newswire

15:50

Sands Capital Life Sciences Pulse Fund II buys 2.07M shares of Inhibikase Therapeutics at $1.45/share.

04:40

Inhibikase shares jump 12.42% premarket after pricing $100M public offering at $1.45/share and $1.449 pre-funded warrants.

03:14

Inhibikase Therapeutics Raises $100M Through Public Offering

16:24

Inhibikase shares rise 11.11% after-hours after announcing public offering of common stock and pre-funded warrants.

16:17

Inhibikase Therapeutics: Forward-Looking Statements and Safe Harbor Provision

View More

About IKT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More